title: Serotoninergic and suprachiasmatic nucleus involvement in the corticotropic response to systemic endotoxin challenge in rats.
abstract: We have investigated whether the serotonin system participates in the mechanisms underlying the corticotropic response in experimentally infected rats. Intra-arterial injection of lipopolysaccharide (LPS; 25 microg/kg b.w.) resulted in a slight but significant increase in serotonin (5-HT) metabolism, detectable 60 min after the stimulus and lasting more than 480 min. Adrenocorticotropin (ACTH) and corticosterone (CORT) responses in intact rats conformed to earlier reports, increasing as early as 30 min after LPS injection and reaching maximal concentrations in the circulation 60 min after the bacterial endotoxin injection. Plasma concentrations of interleukin-1beta (IL-1beta) increased only after 60 min, reaching maximal levels 120 min after LPS. Depletion of hypothalamic 5-HT (-93%) by pretreatment of the animals with para-chlorophenylalanine (p-CPA), resulted in a halved ACTH response to LPS, despite an overall unchanged secretory pattern. Neither CORT nor IL-1beta secretory patterns were affected in these rats pretreated with p-CPA. Complete bilateral electrochemical lesions of the suprachiasmatic nucleus (SCN), which is innervated by mesencephalic 5-HT, impaired the early phase of the ACTH (-75% at 30 min) and CORT (-40% at 30 min) responses but did not affect the later increases of the corticotropic and the plasma IL-1beta responses following the LPS injection. These results indicate that serotonin pathways and SCN are involved in the earlier mechanisms of corticotropic axis recruitment following systemic LPS endotoxemia.
authors.affiliation: Laboratoire de Plasticité Cérébrale, EP-628 CNRS, Université Montpellier 2, Montpellier, France. Lgivalois@univ.montp2.fr
authors.forename: L
authors.initials: L
authors.lastname: Givalois
authors.forename: H
authors.initials: H
authors.lastname: Becq
authors.forename: P
authors.initials: P
authors.lastname: Siaud
authors.forename: G
authors.initials: G
authors.lastname: Ixart
authors.forename: I
authors.initials: I
authors.lastname: Assenmacher
authors.forename: G
authors.initials: G
authors.lastname: Barbanel
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000818:Animals; D003345:Corticosterone / Q000097:blood*; D010134:Fenclonine / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007211:Indoles / Q000378:metabolism; D007375:Interleukin-1 / Q000097:blood; D007700:Kinetics; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D013493:Suprachiasmatic Nucleus / Q000502:physiology* / Q000601:surgery
chemical_list: D007211:Indoles; D007375:Interleukin-1; D008070:Lipopolysaccharides; D012702:Serotonin Antagonists; D012701:Serotonin; C067042:indolamine; D000324:Adrenocorticotropic Hormone; D010134:Fenclonine; D003345:Corticosterone